CHANGES IN COAGULATION HAEMOSTASIS IN PATIENTS WITH RENAL DISEASE AFTER COVID-19: A COMPREHENSIVE REVIEW

dc.contributor.author	Madazimova D.Kh.
dc.date.accessioned	2026-06-05T11:37:07Z
dc.date.available	2026-06-05T11:37:07Z
dc.date.issued	2026
dc.identifier.uri	http://repo.tma.uz/xmlui/handle/1/4113
dc.description.abstract	Coronavirus disease 2019 (COVID-19) causes significant disturbances in haemostasis that may persist after clinical recovery. Patients with chronic kidney disease (CKD) and those on dialysis represent a vulnerable group due to their preexisting haemostatic alterations and increased thrombotic risk. This review examines the pathophysiological mechanisms, laboratory abnormalities, clinical manifestations, and management strategies for coagulation disturbances in patients with renal impairment after COVID-19. The challenges in balancing thrombotic and hemorrhagic complications are discussed alongside recommendations for anticoagulation in this population.	en_US
dc.language.iso	en_US	en_US
dc.publisher	O'zbekiston, Toshkent (Медицинский вестник Узбекистана)	en_US
dc.subject	COVID-19, coagulation, haemostasis, chronic kidney disease, dialysis, thrombosis, bleeding risk	en_US
dc.title	CHANGES IN COAGULATION HAEMOSTASIS IN PATIENTS WITH RENAL DISEASE AFTER COVID-19: A COMPREHENSIVE REVIEW	en_US
dc.type	Article	en_US